Diagnostic significance of IgG and albumin indices versus oligoclonal band types in demyelinating disorders.


Journal

Journal of clinical pathology
ISSN: 1472-4146
Titre abrégé: J Clin Pathol
Pays: England
ID NLM: 0376601

Informations de publication

Date de publication:
Mar 2023
Historique:
received: 14 06 2021
accepted: 29 08 2021
pubmed: 17 9 2021
medline: 25 2 2023
entrez: 16 9 2021
Statut: ppublish

Résumé

The laboratory diagnosis of demyelinating inflammatory disorders (DIDs) relies on both intrathecal oligoclonal band (OCB) positivity and IgG index. Although OCB typing remains the gold-standard test for DIDs, it can be laborious and ambiguous, complicating diagnostics, and unduly increasing diagnostic time. We examined whether serum or cerebrospinal fluid (CSF) parameters can classify OCB types and, thus, be used as a replacement test to standard OCB typing. We retrospectively analysed >1000 prospectively collected samples of patients with DIDs and quantified albumin and IgG levels in the CSF and serum. We determined OCB types by isoelectric focusing combined with immunofixation and evaluated the diagnostic accuracies of IgG and albumin indices in discriminating OCB types by receiver operating characteristic curves and multinomial regression. An IgG index cut-off of 0.589 differentiated types 2/3 from types 1/4 (area under the curve 0.780, 95% CI 0.761 to 0.812, p<0.001; specificity: 71.10%, sensitivity: 73.45%). Albumin quotient cut-off values of 6.625 and of 6.707 discriminated type 1 from type 4 and type 2 from type 3, respectively (specificity: <55%, sensitivity: <75%). Female sex, age, IgG index, CSF IgG and serum albumin were associated with different OCB types. Our study reveals that IgG and albumin index can differentiate OCB types with adequate accuracy, especially if refined by age and gender.

Identifiants

pubmed: 34526372
pii: jclinpath-2021-207766
doi: 10.1136/jclinpath-2021-207766
doi:

Substances chimiques

Oligoclonal Bands 0
Immunoglobulin G 0
Albumins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

166-171

Informations de copyright

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Maria Belimezi (M)

Diagnostic Services Laboratory, Hellenic Pasteur Institute, Athens, Greece.

Antonios Kalliaropoulos (A)

Diagnostic Services Laboratory, Hellenic Pasteur Institute, Athens, Greece.

Alexios-Fotios A Mentis (AA)

Diagnostic Services Laboratory, Hellenic Pasteur Institute, Athens, Greece mentisaf@gmail.com.
University Research Institute of Maternal and Child Health and Precision Medicine, National and Kapodistrian University of Athens, Athens, Greece.

George P Chrousos (GP)

University Research Institute of Maternal and Child Health and Precision Medicine, National and Kapodistrian University of Athens, Athens, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH